174 related articles for article (PubMed ID: 37341009)
1. Effectiveness of fosfomycin-based antimicrobial prophylaxis for transrectal ultrasound-guided prostate biopsy: A Korean multicenter study.
Lim DG; Jung SI; Hwang EC; Kim TH; Bae S; Huh JS; Lee SJ; Chung H; Choi H
Investig Clin Urol; 2023 May; 64(3):289-295. PubMed ID: 37341009
[TBL] [Abstract][Full Text] [Related]
2. Comparison of a combined regimen of fosfomycin and ciprofloxacin with ciprofloxacin alone as antimicrobial prophylaxis for transrectal prostate biopsy in the era of high fluoroquinolone-resistant rectal flora.
Lim DG; Jung SI; Kim MS; Chung HS; Hwang EC; Kwon DD
Prostate Int; 2021 Sep; 9(3):163-168. PubMed ID: 34692590
[TBL] [Abstract][Full Text] [Related]
3. Comparison of fosfomycin against fluoroquinolones for transrectal prostate biopsy prophylaxis: an individual patient-data meta-analysis.
Roberts MJ; Scott S; Harris PN; Naber K; Wagenlehner FME; Doi SAR
World J Urol; 2018 Mar; 36(3):323-330. PubMed ID: 29288398
[TBL] [Abstract][Full Text] [Related]
4. Trial Comparing a Combined Regimen of Amikacin and Ciprofloxacin to Ciprofloxacin Alone as Transrectal Prostate Biopsy Prophylaxis in the Era of High Fluoroquinolone-Resistant Rectal Flora.
Son KC; Chung HS; Jung SI; Kim MS; Hwang EC; Kim JW; Kwon DD
J Korean Med Sci; 2018 Apr; 33(15):e113. PubMed ID: 29629517
[TBL] [Abstract][Full Text] [Related]
5. Comparison of amikacin with fosfomycin as an add-on to ciprofloxacin for antibiotic prophylaxis in transrectal prostate biopsy: A single-center retrospective study.
Yu SH; Jung SI; Ryu JW; Kim MS; Chung HS; Hwang EC; Kwon DD
Investig Clin Urol; 2022 Nov; 63(6):663-670. PubMed ID: 36347556
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of fosfomycin compared to second generation cephalosporin flumarin as antimicrobial prophylaxis for transrectal ultrasound-guided prostate biopsy: a single center retrospective study.
Kim HY; Lim D; Choi YH; Yoo JM; Lee DS; Lee SJ
BMC Urol; 2023 Dec; 23(1):211. PubMed ID: 38114968
[TBL] [Abstract][Full Text] [Related]
7. Complication Rate After Antibiotic Prophylaxis with Fosfomycin Versus Fluorochinolones or β-lactam Antibiotics in Patients Undergoing Prostate Biopsy: A Propensity Score-adjusted Analysis.
Cimino S; Verze P; Venturino L; Alessio P; Migliara A; Imbimbo C; Mirone V; Russo GI; Morgia G
Eur Urol Focus; 2020 Mar; 6(2):370-375. PubMed ID: 30007542
[TBL] [Abstract][Full Text] [Related]
8. The effectiveness of targeted relative to empiric prophylaxis on infectious complications after transrectal ultrasound-guided prostate biopsy: a meta-analysis.
Scott S; Harris PN; Williamson DA; Liss MA; Doi SAR; Roberts MJ
World J Urol; 2018 Jul; 36(7):1007-1017. PubMed ID: 29453690
[TBL] [Abstract][Full Text] [Related]
9. Baseline prevalence of antimicrobial resistance and subsequent infection following prostate biopsy using empirical or altered prophylaxis: A bias-adjusted meta-analysis.
Roberts MJ; Williamson DA; Hadway P; Doi SA; Gardiner RA; Paterson DL
Int J Antimicrob Agents; 2014 Apr; 43(4):301-9. PubMed ID: 24630305
[TBL] [Abstract][Full Text] [Related]
10. Fosfomycin-trometamol (FT) or fluoroquinolone (FQ) as single-dose prophylaxis for transrectal ultrasound-guided prostate biopsy (TRUS-PB): A prospective cohort study.
Delory T; Goujon A; Masson-Lecomte A; Arias P; Laurancon-Fretar A; Bercot B; Mongiat-Artus P; Molina JM; Lafaurie M
Int J Infect Dis; 2021 Jan; 102():269-274. PubMed ID: 33129963
[TBL] [Abstract][Full Text] [Related]
11. Effectiveness of fosfomycin tromethamine prophylaxis in preventing infection following transrectal ultrasound-guided prostate needle biopsy: Results from a large Canadian cohort.
Carignan A; Sabbagh R; Masse V; Gagnon N; Montpetit LP; Smith MA; Raymond M; Allard C; Bergeron C; Pépin J
J Glob Antimicrob Resist; 2019 Jun; 17():112-116. PubMed ID: 30553114
[TBL] [Abstract][Full Text] [Related]
12. Fluoroquinolone-resistant E. coli in intestinal flora of patients undergoing transrectal ultrasound-guided prostate biopsy--should we reassess our practices for antibiotic prophylaxis?
Steensels D; Slabbaert K; De Wever L; Vermeersch P; Van Poppel H; Verhaegen J
Clin Microbiol Infect; 2012 Jun; 18(6):575-81. PubMed ID: 21958149
[TBL] [Abstract][Full Text] [Related]
13. Fluoroquinolone-resistant Escherichia coli among the rectal flora is the predominant risk factor for severe infection after transrectal ultrasound-guided prostate biopsy: a prospective observational study.
Holmbom M; Forsberg J; Fredrikson M; Nilsson M; Nilsson LE; Hanberger H; Hällgren A
Scand J Urol; 2023 Aug; 58():32-37. PubMed ID: 37553957
[TBL] [Abstract][Full Text] [Related]
14. Implications of faecal ESBL carriers undergoing TRUS-guided prostate biopsy (TRUSPB): role of screening prior to TRUSPB.
Bhatt NR; Murphy CA; Wall N; McEvoy E; Flynn RJ; Thomas AZ; Manecksha RP; Murphy PG; Smyth LG
Ir J Med Sci; 2020 Aug; 189(3):817-823. PubMed ID: 31873877
[TBL] [Abstract][Full Text] [Related]
15. Targeted antimicrobial prophylaxis using rectal swab cultures in men undergoing transrectal ultrasound guided prostate biopsy is associated with reduced incidence of postoperative infectious complications and cost of care.
Taylor AK; Zembower TR; Nadler RB; Scheetz MH; Cashy JP; Bowen D; Murphy AB; Dielubanza E; Schaeffer AJ
J Urol; 2012 Apr; 187(4):1275-9. PubMed ID: 22341272
[TBL] [Abstract][Full Text] [Related]
16. The role of targeted prophylactic antimicrobial therapy before transrectal ultrasonography-guided prostate biopsy in reducing infection rates: a systematic review.
Cussans A; Somani BK; Basarab A; Dudderidge TJ
BJU Int; 2016 May; 117(5):725-31. PubMed ID: 26709240
[TBL] [Abstract][Full Text] [Related]
17. Comparison of Single and Prolonged Fluoroquinolone Prophylaxis and Risk Factors for Infectious Complications After Transrectal Prostate Biopsy.
Kalkanlı A; Gezmiş CT; Özkan A; Çilesiz NC; Yanaral F; Aydın M; Tandoğdu Z
Balkan Med J; 2018 Sep; 35(5):373-377. PubMed ID: 29866640
[TBL] [Abstract][Full Text] [Related]
18. Rectal Culture-Guided Targeted Antimicrobial Prophylaxis Reduces the Incidence of Post-Operative Infectious Complications in Men at High Risk for Infections Submitted to Transrectal Ultrasound Prostate Biopsy - Results of a Cross-Sectional Study.
Boeri L; Fontana M; Gallioli A; Zanetti SP; Catellani M; Longo F; Mangiarotti B; Montanari E
PLoS One; 2017; 12(1):e0170319. PubMed ID: 28122053
[TBL] [Abstract][Full Text] [Related]
19. Povidone-iodine rectal cleansing and targeted antimicrobial prophylaxis using rectal swab cultures in men undergoing transrectal ultrasound-guided prostate biopsy are associated with reduced incidence of postoperative infectious complications.
Ryu JW; Jung SI; Ahn JH; Hwang EC; Yu HS; Kang TW; Kwon DD; Park K; Kim JW
Int Urol Nephrol; 2016 Nov; 48(11):1763-1770. PubMed ID: 27495324
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of fluoroquinolone-resistant rectal flora in patients undergoing transrectal ultrasound-guided prostate needle biopsy: A prospective multicenter study.
Chung HS; Hwang EC; Yu HS; Jung SI; Lee SJ; Lim DH; Cho WJ; Choe HS; Lee SJ; Park SW
Int J Urol; 2018 Mar; 25(3):278-283. PubMed ID: 29241300
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]